SFI
PHIO icon

Susquehanna Fundamental Investments’s Phio Pharmaceuticals PHIO Stock Holding History

Susquehanna Fundamental Investments’s Portfolio PHIO Stock Details PHIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-165
Closed -$48K – 1745
2021
Q1 		$48K Buy
+165
New +$54.9K ﹤0.01% 1499

Other funds holding PHIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna Fundamental Investments's PHIO Position: Q2 2021 in Review

Susquehanna Fundamental Investments sold out of Phio Pharmaceuticals (PHIO) in Q2 2021, closing a stake of 165 shares — an estimated $48K sold.

Susquehanna Fundamental Investments first reported a position in PHIO in Q1 2021 and held it in 1 quarter. The position peaked at $48K in Q1 2021. 17 funds tracked by Wall St. Rank hold PHIO as of Q2 2021.

  • Susquehanna Fundamental Investments reported no remaining Phio Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Susquehanna Fundamental Investments sold 165 Phio Pharmaceuticals shares in Q2 2021, an estimated $48K.
  • Susquehanna Fundamental Investments first reported a position in Phio Pharmaceuticals in Q1 2021 and held it in 1 quarter.
  • Susquehanna Fundamental Investments's Phio Pharmaceuticals position peaked at $48K in Q1 2021.
  • 17 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q2 2021.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2021, filed 11 Aug 2021.